NCT02646995View on ClinicalTrials.gov

Lipid Formulation to Increase the Bioavailability of Fatty Acids in Cystic Fibrosis (CF) Patients

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 27, 2017

Study Completion Date

May 4, 2017

Conditions
Cystic Fibrosis
Interventions
DIETARY_SUPPLEMENT

modified lipid formulation

Tested oils will be used in liquid form and encapsulated in soft gelatin capsules.

DIETARY_SUPPLEMENT

Fish oil

Fish oil will be used in liquid form and encapsulated in soft gelatin capsules.

Trial Locations (1)

1011

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT02646995 - Lipid Formulation to Increase the Bioavailability of Fatty Acids in Cystic Fibrosis (CF) Patients | Biotech Hunter | Biotech Hunter